0001104659-24-043291.txt : 20240403 0001104659-24-043291.hdr.sgml : 20240403 20240403215550 ACCESSION NUMBER: 0001104659-24-043291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DELUCCIA ROBERT J CENTRAL INDEX KEY: 0001127423 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40536 FILM NUMBER: 24821478 MAIL ADDRESS: STREET 1: 40 WASHINGTON STREET STREET 2: SUITE 220 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 BUSINESS PHONE: 917-533-1469 MAIL ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 FORMER COMPANY: FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC DATE OF NAME CHANGE: 20180402 4 1 tm2411025-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-23 0 0001736243 Acurx Pharmaceuticals, Inc. ACXP 0001127423 DELUCCIA ROBERT J C/O ACURX PHARMACEUTICALS, INC., 259 LIBERTY AVENUE STATEN ISLAND NY 10305 1 0 1 0 0 Stock Option 3.15 2024-02-23 4 A 0 250000 0 A 2034-02-22 Common Stock 250000 250000 D On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person. /s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia 2024-04-03